Plan B Decision Mobilizes House Members To Seek FDA Integrity Review

A House bill directing FDA to conduct a formal review of the process leading up to its decision to designate as "not approvable" the Rx-to-OTC switch application for the Plan B emergency contraceptive was introduced by Rep. Carolyn Maloney (D-N.Y.) on May 14